Bristol-Myers Squibb - About Us - Corporate Compliance

Welcome Message

Our Company

Awards & Recognition

Corporate Governance

Corporate Compliance

	Description of Comprehensive Compliance Program (PDF)
	Annual Declaration of Compliance (PDF)

Our Websites

Business Links

» BMS.com Home » About Us » Corporate Compliance » California Compliance Law

California Compliance Law

These documents are provided in accordance with California Health and Safety Code Sections 119400-119402. A copy of these documents may be obtained by calling the toll-free number 1-800-348-5526.

Description for the State of California of the Bristol-Myers Squibb Comprehensive Compliance Program (PDF: 4 pages)

Annual Declaration of Compliance for the State of California (PDF: 1 page)

The Annual Declaration is effective as of April 1, 2008 for the January 1, 2007 through December 31, 2007 declaration period. Our next annual declaration will be made in 2009 for calendar year 2008.

[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.